These authors contributed equally to this work.
A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia
Version of Record online: 22 JAN 2013
Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
EMBO Molecular Medicine
Volume 5, Issue 3, pages 353–365, March 2013
How to Cite
Zhu, J., Zhou, L., Wu, G., Konig, H., Lin, X., Li, G., Qiu, X.-L., Chen, C.-F., Hu, C.-M., Goldblatt, E., Bhatia, R., Chamberlin, A. R., Chen, P.-L. and Lee, W.-H. (2013), A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Mol Med, 5: 353–365. doi: 10.1002/emmm.201201760
- Issue online: 5 MAR 2013
- Version of Record online: 22 JAN 2013
- Manuscript Revised: 27 NOV 2012
- Manuscript Accepted: 27 NOV 2012
- Manuscript Received: 19 JUL 2012
- Funded Access
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.